Prestige Biologics Co Ltd - ESG Rating & Company Profile powered by AI
Browse to the end of the webpage for potential risks for Prestige Biologics Co Ltd based on sector, geography and size. Other corporations in the scoring industry group for Prestige Biologics Co Ltd are shown below. If you work at Prestige Biologics Co Ltd and you would like to use your Sustainability aseessment, please get in touch.
Prestige Biologics Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Prestige Biologics Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Prestige Biologics Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Prestige Biologics Co Ltd disclose current and historical energy intensity?
Does Prestige Biologics Co Ltd report the average age of the workforce?
Does Prestige Biologics Co Ltd reference operational or capital allocation in relation to climate change?
Does Prestige Biologics Co Ltd disclose its ethnicity pay gap?
Does Prestige Biologics Co Ltd disclose cybersecurity risks?
Does Prestige Biologics Co Ltd offer flexible work?
Does Prestige Biologics Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Prestige Biologics Co Ltd disclose the number of employees in R&D functions?
Does Prestige Biologics Co Ltd conduct supply chain audits?
Does Prestige Biologics Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Prestige Biologics Co Ltd conduct 360 degree staff reviews?
Does Prestige Biologics Co Ltd disclose the individual responsible for D&I?
Does Prestige Biologics Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Prestige Biologics Co Ltd disclose current and / or historical scope 2 emissions?
Does Prestige Biologics Co Ltd disclose water use targets?
Does Prestige Biologics Co Ltd have careers partnerships with academic institutions?
Did Prestige Biologics Co Ltd have a product recall in the last two years?
Does Prestige Biologics Co Ltd disclose incidents of discrimination?
Does Prestige Biologics Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Prestige Biologics Co Ltd issued a profit warning in the past 24 months?
Does Prestige Biologics Co Ltd disclose parental leave metrics?
Does Prestige Biologics Co Ltd disclose climate scenario or pathway analysis?
Does Prestige Biologics Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Prestige Biologics Co Ltd disclose the pay ratio of women to men?
Does Prestige Biologics Co Ltd support suppliers with sustainability related research and development?
Does Prestige Biologics Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Prestige Biologics Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Prestige Biologics Co Ltd involved in embryonic stem cell research?
Does Prestige Biologics Co Ltd disclose GHG and Air Emissions intensity?
Does Prestige Biologics Co Ltd disclose its waste policy?
Does Prestige Biologics Co Ltd report according to TCFD requirements?
Does Prestige Biologics Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Prestige Biologics Co Ltd disclose energy use targets?
Does Prestige Biologics Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Prestige Biologics Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Prestige Biologics Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. Its product candidates include Herceptin for breast and stomach cancer; Avastin for colon, lung, and ovarian cancers; Humira for arthritis; PBP1510 for pancreatic cancer; Denosumab for bone loss, osteoporosis; Aflibercept for macular edema and metastatic colorectal cancer; Eculizumab for atypical haemolytic uremic syndrome; Ipilimumab for metastatic melanoma; and PBP1710 for solid tumors. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was founded in 2015 and is based in Cheongju-si, South Korea.